bibliographicCitation |
Kurzrock R, Talpaz M, Li L, Estrov Z. Distinct biological impact of dephosphorylation vs. downregulation of p210Bcr-Abl: Implications for imatinib mesylate response and resistance. Leukemia & Lymphoma. 2006 Jan;47(8):1651–64. doi: 10.1080/10428190600709572. |